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INTRODUCTION
Until date, over 200 alpha chain variants have been identified. [1] Most of these were picked up during hemoglobinopathy screening programs. Studies involving the spectrum and frequency of alpha globin chain variants in India are very few. [2] The clinical importance of alpha chain variants lies in the moderation they cause in the phenotype and severity of clinical manifestations of other globin chain disorders, especially beta globin chain defects, when co-inherited with the latter. This is very well demonstrated by the first report of hemoglobin (Hb) Fontainebleau from India, wherein a woman and her baby were found to have Hb Fontainebleau, a rare alpha globin chain variant, [3] in a compound heterozygous state with HbS. [4] Here, we report a case of Hb Fontainebleau [alpha 21(B2) Ala→Pro] detected in heterozygous condition in a primigravida as a part of her antenatal screening. This would be the fourth case of Hb Fontainebleau reported from the Indian subcontinent.
CASE HISTORY
A 19-year-old Sikh female, born of nonconsanguineous marriage, underwent Hb variant analysis as a part of her routine antenatal screening. She had no previous history of anemia or blood transfusions. Laboratory investigations revealed Hb 11.6 g/dl with red cell count 4.82 × 10 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
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Red cell distribution width was 15.7%. Hb variant analysis carried out by high-performance liquid chromatography (HPLC) on the variant II Hb testing system (Bio Rad Laboratories, Hercules, CA, USA) revealed a small abnormal Hb peak (12.5%) with a retention time of 2.92 min, appearing as a hump following and close to the HbA peak [ Figure 1a ]. The other Hbs seen in HPLC were HbA (83.6%), HbA 2 (1.7%), and Hb F (0.3%).
The proband's father revealed the presence of a similar abnormal Hb peak (12.6%) with a retention time of 2.93 min on HPLC analysis. His HbA 2 was 2.5% and HbF was 0.2%. His hemogram was normal.
Molecular characterization of the abnormal Hb in the proband's father by reverse DNA sequencing (Applied Biosystems, Foster City, USA) showed the presence of a heterozygous G>C substitution at codon 21 (alpha 2 globin gene) [ Figure 1d ], leading to the substitution of alanine by proline at the beginning of the beta helix corresponding to Hb Fontainebleau.
Hb variant analysis of the index case's husband showed an elevated Hb A 2 of 5.7% along with a sharp abnormal Hb peak (8.3%) with a retention time of 4.67 min, followed immediately by a very small Hb peak [ Figure 1b ]. This suggested a compound heterozygous state for HbQ India and beta-thalassemia.
The proband's baby could be investigated at the age of 7 months after much persuasion of the parents. She had microcytic hypochromic anemia (Hb 8.5 g/dl; MCV 57.8 fl; MCH 16.9 pg; and MCHC 29.3 g/dl) and was compound heterozygous for HbQ India (9.2%; retention time: 4.65 min) and beta-thalassemia (HbA2: 6.3%) [ Figure 1c ] like her father. The HbA2 peak in both the father and daughter was asymmetric and showed a small hump in the descending limb of the peak. The baby also had mildly elevated HbF (8.5%), which was consistent with her age.
DISCUSSION
Hb Fontainebleau is a rare alpha chain variant that elutes out as a hump close to the descending limb of the HbA peak in HPLC and can pose considerable diagnostic difficulty to those unfamiliar with this entity. [3, 4] However, Hb Fontainebleau has not been found to be associated with any hematological abnormality in earlier reports from different parts of the world, including India. [3] [4] [5] [6] [7] Our index patient and her father, both of whom had Hb Fontainebleau, did not show any clinical or hematological finding related to the presence of this alpha chain variant. The mildly reduced Hb value and microcytic red cell indices in her could have resulted from pregnancy associated changes and a concomitant iron deficiency. In addition, her HbA 2 level was low as has been previously reported in some other cases. [5] Interestingly, the compound heterozygosity for beta thalassemia trait and another alpha globin chain variant, HbQ India in the proband's husband raised the following possibilities for the genotypes of the unborn baby when we first examined the couple, 1. Compound heterozygosity for Hb Fontainebleau and HbQ India 2. Heterozygous state for only Hb Fontainebleau or HbQ India 3. Compound heterozygosity for Hb Fontainebleau and beta thalassemia trait 4. Compound heterozygosity for HbQ India and beta thalassemia trait 5. Co-inheritance of all the three abnormalities, namely, Hb Fontainebleau, HbQ India, and beta thalassemia trait.
The baby, however, was found to have inherited HbQ India and beta thalassemia trait from her father and no Hb Fontainebleau from the mother [ Figure 1c ]. That the sharp abnormal Hb peaks in HbS window (retention time 4.65-4.67 min) in the baby and her father were indeed HbQ India was supported by (i) the small hump and a protracted slope of the descending limb of the HbA2 peak in HPLC as compared to the mother's symmetric HbA2 peak, caused by a variant HbA2 resulting from combination of the abnormal alpha chain of HbQ India with the normal delta chain; (ii) very small S-window peaks appearing as slight irregularities [ Figures 1b and c] ; and (iii) the small post-HbQ peak has been observed in HPLC of this abnormal Hb and other alpha chain variants in published reports. [8, 9] As previously reported in compound heterozygotes of HbQ India and beta thalassemia trait, HbQ levels in the husband and the daughter of the index case (8.3% and 9.2%, respectively) were lower than those observed in simple hererozygotes of HbQ India (mean level 20%). [8, 10] This could reflect an attempt by red cells to preferentially synthesize HbA at the cost of HbQ when beta thalassemia is co-inherited.
[10] The baby's anemia and microcytic hypochromic red cell indices could have resulted from the interplay of coexistent iron deficiency -not uncommon at her age -and beta thalassemia trait because HbQ India is not associated with microcytosis.
The parents of the baby have been counseled about the various genotypic and phenotypic possibilities (listed above) of their future offspring and the clinical implications thereof.
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